The Department of Health and Human Services today announced that later this week it will distribute $9 billion of the $17 billion in Provider Relief Fund “Phase 4” payments to providers who have experienced revenue losses and expenses related to the COVID-19 pandemic. In addition, HHS stated that it is currently reviewing the remaining Phase 4 applications and will make the remainder of Phase 4 payments in 2022. 

In today’s announcement, HHS stated that more than 69,000 providers will receive Phase 4 payments beginning Dec. 16. The average payment for small providers is $58,000, for medium providers $289,000, and for large providers $1.7 million. The Health Resources and Services Administration processed approximately 75% of Phase 4 applications; remaining Phase 4 applications require additional review, and HRSA will make the remainder of the payments next year. 

Consistent with the Phase 4 payment methodology released by HRSA in September, approximately 75% of Phase 4 funding is being distributed based on expenses and decreased revenue from July 1, 2020 to March 31, 2021. Smaller providers will be reimbursed at a higher percentage of losses and expenses as compared to larger providers. The remaining 25% of Phase 4 funding is being distributed as “bonus” payments based on the amount and type of services provided to Medicare, Medicaid or Children’s Health Insurance Program patients. HRSA is using Medicare reimbursement rates in calculating these payments. 
 

Related News Articles

Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…